Literature DB >> 620495

Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy.

R Wootton, J Reeve, E Spellacy, M Tellez-Yudilevich.   

Abstract

1. Blood flow to the skeleton was measured by the 18F clearance method of Wooton, Reeve & Veall (1976) in 24 patients with untreated Paget's disease. In every patient but one, resting skeletal blood flow was increased. There was a significant positive correlation between skeletal blood flow and serum alkaline phosphatase and between skeletal blood flow and urinary total hydroxyproline excretion. 2. Fourteen patients were re-studied after they had received short-term (7 days or less) or long-term (7 weeks or more) calcitonin. Skeletal blood flow, alkaline phosphatase and urinary hydroxy-proline excretion fell towards normal in every case. There was some evidence from the short-term studies that calcitonin produced a more rapid fall in skeletal blood flow than in alkaline phosphatase. 3. Glomerular filtration rate appeared to increase transiently in response to calcitonin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620495     DOI: 10.1042/cs0540069

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  10 in total

1.  Plasma prostaglandin E levels in Paget's disease: effect of indomethacin.

Authors:  D T Baran; B M Jaffe; L V Avioli
Journal:  Calcif Tissue Int       Date:  1979-11       Impact factor: 4.333

2.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

3.  Calcitonin for pseudoclaudication in lumbar spinal stenosis.

Authors:  J Streifler; R Hering; N Gadoth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

Review 4.  Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone.

Authors:  Rhonda D Prisby
Journal:  J Endocrinol       Date:  2017-08-16       Impact factor: 4.286

Review 5.  Paget's disease of bone: diagnosis and management.

Authors:  D Hosking; P J Meunier; J D Ringe; J Y Reginster; C Gennari
Journal:  BMJ       Date:  1996-02-24

Review 6.  Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology.

Authors:  Emily M Rabjohns; Katlyn Hurst; Arin Ghosh; Maria C Cuellar; Rishi R Rampersad; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-25       Impact factor: 4.806

Review 7.  Clinical efficacy of salmon calcitonin in Paget's disease of bone.

Authors:  F R Singer
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

8.  Skeletal blood flow measured with 18F in patients with osteomalacia and hyperparathyroidism.

Authors:  M Tellez; R Wootton; J Reeve
Journal:  Eur J Nucl Med       Date:  1983

Review 9.  Paget disease: when to treat and when not to treat.

Authors:  Frederick R Singer
Journal:  Nat Rev Rheumatol       Date:  2009-08-04       Impact factor: 20.543

10.  Paget's disease of bone. An update on management.

Authors:  D J Hosking
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.